Clinical Trials Directory

Trials / Completed

CompletedNCT02440711

Evaluation of a Modified Running-specific Prosthetic Foot

Endurance, Energy Expenditure, Perceived Function, and Satisfaction of Persons With Transtibial Limb Loss Using a Running-Specific Prosthesis Modified for Walking

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional energy storing prosthetic foot (ESF) and a novel modified running-specific prosthesis (mRSF). A randomized cross-over study will be conducted to determine if the mRSF provides superior performance to the ESF, which is commonly prescribed to most active individuals with lower limb amputation.

Detailed description

Amputation of a limb is a life-altering event with profound physical, psychological, and social implications. To address their functional, vocational, and recreational needs, people with lower limb amputation (LLA) are often provided with a prosthesis or artificial leg. While use of a prosthesis can allow an individual to achieve a basic level of functional mobility, absence of an anatomical foot and ankle still impairs their physical performance. As a result, people with LLA regularly exhibit decreased walking speeds, diminished endurance, and restricted ability to participate in desired life situations. Over the past three decades, increasingly sophisticated prosthetic foot designs have been developed by the prosthetics industry to replace amputated structures in the leg. Contemporary, energy storing feet (ESF) employ advanced materials and unique geometric designs to improve walking performance and endurance of their users. Although prosthetic limbs with ESF allow people with LLA the potential to return to an active lifestyle, even the most advanced ESF do not significantly reduce the increased energy demands required for walking when compared to conventional prosthetic feet. Commercially-available running-specific feet (RSF) like the Össur Cheetah (Össur, Reykjavik, Iceland) allow people with LLA to participate in athletic activities and sporting events. RSF provide significantly enhanced performance, compared to traditional ESF, by extending the length and increasing the stiffness of the prosthetic keel (forefoot). RSF also do not include a heel, as they are used only for running activities. Although transtibial runners with RSF exhibit endurance levels similar to non-amputees, the RSF design does not allow the biomechanical movements or provide the stability needed to use the foot for walking (over level or uneven terrain). A novel modified running-specific foot (mRSF) has been developed to integrate the performance of a RSF with the utility of an ESF. The mRSF combines the running keel (forefoot) of a RSF with the walking heel of a ESF. The mRSF can then be used for walking, running, and other routine daily activities. Preliminary feedback on the mRSF suggests that users experience improved overall function and high satisfaction with the device. However, empirical evidence is needed to support prescription of this prosthetic foot at other clinical facilities. The goal of this study is therefore to evaluate endurance, walking performance, mobility, and perceived exertion of transtibial prosthesis users (i.e., study participants) walking with a conventional ESF and the mRSF. Results will be compared to determine if the mRSF provides superior performance to the ESF, which is commonly prescribed to most active individuals with LLA.

Conditions

Interventions

TypeNameDescription
DEVICEEnergy storing foot (ESF)A commercially-available energy storing prosthetic foot
DEVICEModified running specific foot (mRSF)A running specific prosthetic foot customized for both running and walking activities

Timeline

Start date
2015-05-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2015-05-12
Last updated
2023-08-02
Results posted
2023-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02440711. Inclusion in this directory is not an endorsement.